Introduction {#sec0005}
============

*Helicobacter cinaedi* is a Gram-negative spiral rod and was first isolated from rectum in homosexual men with proctocolitis in 1984 [@bib0035]. *H. cinaedi* inhabits the gastrointestinal tract of mammals. *H. cinaedi* has been increasingly reported to cause many types of infections, and has been isolated from both immunocompetent and immunocompromised patients. Proctocolitis is first reported [@bib0035], however, more invasive diseases such as bacteremia, cellulitis, arthritis, osteomyelitis, and meningitis have been recently reported. Cellulitis among immunocompromised patients is often multi-focal [@bib0040], however, among immunocompetent patients, multi-focal cellulitis is rare. In the literature, approximately 30--60% of patients have recurrent symptoms [@bib0045]. Longer antimicrobial treatment may be required.

We report here an immunocompetent patient with *H. cinaedi* bacteremia complicated with bilateral lower extremities skin and soft tissue infections which was refractory to treat and required a prolonged antimicrobial treatment.

Case report {#sec0010}
===========

A 54-year-old Japanese man with past medical history of hypertension presented with one month history of fever, bilateral lower extremities pain and erythema. The patient had been well until approximately one month prior to admission, when he noted fever, pain and redness in the bilateral lower extremities. He had no history of injuries. Five days prior to admission, he was seen by his primary care physician, and given a diagnosis of cellulitis in the bilateral lower extremities. Two sets of blood culture were obtained and oral levofloxacin 500 mg daily was prescribed. Four days later, blood cultures turned positive for Gram-negative spiral rod. Then he was admitted to our hospital for further investigation.

On admission, he had mild pain in the bilateral lower extremities. He denied sore throat, running nose, fatigue, chills, night sweats, weight changes, abdominal pain, nausea, vomiting, diarrhea, dysuria, and frequency. He did not use illicit drugs. He denied homosexual contact, any trauma, insect bites, or contact with animals. The temperature was 36.5 °C, the blood pressure was 157/79 mm Hg, and the heart rate was 51 beats/min, respirations 16/min. He had symmetrical tenderness and erythema in the bilateral lower dorsal part of the extremities ([Fig. 1](#fig0005){ref-type="fig"}). The remainder of the physical examinations was normal. The laboratory data showed the white blood cell count was 8200/μl, neutrophils 73%, erythrocyte sedimentation 46 mm/h, otherwise unremarkable. Immunological studies including immunoglobulin, complements were normal. Human Immunodeficiency Virus (HIV) and Human T-cell Lymphoma Virus type-1 serology were both negative. CT of the lower extremities without contrast was normal. Intravenous antimicrobial treatment with meropenem (1 g every 8 h) was started empirically for Gram-negative spiral rod. The patient\'s erythema improved on the second day of admission. On the sixth day of admission, the organism was identified as *H. cinaedi* by polymerase chain reaction. The susceptibility testing showed as follows: Ampicillin, imipenem, and gentamicin were susceptible. Clarithromycin and levofloxacin were resistant. Stool culture obtained while he was on meropenem on the 10th day of admission was negative. Abdominal ultrasound and esophagogastroduodenoscopy showed no significant abnormalities. Colonoscopy showed mild proctitis, however, biopsy specimen showed non-specific inflammation. Transthoracic echocardiogram showed no vegetation. Intravenous meropenem 1 g every 8 h was administered for 14 days. The erythema and pain improved and he was discharged home. Nineteen days after discharge, the patient came back with right lower extremity erythema and pain. He was re-admitted and meropenem 1 g every 8 h was restarted. Blood cultures and stool cultures on admission were both negative. His symptoms improved immediately after the initiation of treatment. Intravenous meropenem was administered for four weeks and then switched to oral minocycline 100 mg twice daily. However, two weeks later, he was re-admitted due to the recurrent right lower extremity pain. Repeated blood cultures this admission were negative. Three week courses of intravenous meropenem was administered followed by oral minocycline 100 mg twice daily for 3 weeks. After the two episodes of recurrence and subsequent prolonged treatment, his symptoms subsided.

Discussion {#sec0015}
==========

We reported a patient with bacteremia with multi-focal skin and soft tissue infections caused by *H. cinaedi* in an immunocompetent patient which was refractory to treat with multiple recurrent episodes. An increasing number of cases of *H. cinaedi* infection among immunocompromised patients has been reported during the last few decades, and it often causes bacteremia and cellulitis [@bib0050]. Recently, *H. cinaedi* infections among immunocompetent patients are increasingly reported especially from Japan [@bib0055]. Cellulitis is often multi-focal among immunocompromised patients [@bib0040], however, among immunocompetent patients, multi-focal cellulitis is rare. *H. cinaedi* resides in the gastrointestinal tract of mammals, and has an ability to invade vascular systems [@bib0045], then causes bacteremia and multi-focal cellulitis. Among patients with community-acquired *H. cinaedi* bacteremia, more than 83.3% of the patients had apparent cellulitis, while patients with healthcare associated *H. cinaedi* bacteremia, only 43.8% of the patients had cellulitis (*p* = 0.078) [@bib0060]. On the basis of the previously reported case series [@bib0035], [@bib0040], [@bib0045], [@bib0050], [@bib0055], [@bib0060], clinical manifestations and severities are determined by the balance between the host\'s immune status and virulence of the organism. The differences of the incidence of cellulitis above could be explained by that the local infiltration of lymphocytes and neutrophils might be inhibited in the immunocompromised patients. That is, if patients with decreased immune systems may have less symptoms including none or solitary cellulitis lesions. To the contrary, patients with decreased immune systems tend to develop severe cellulitis, while the competent immune systems can prevent cellulitis to be multi-focal. The precise pathophysiology of *H. cinaedi* bacteremic infection is not very well understood.

There are currently no standardized treatment in the literature in selection and the duration of antimicrobial treatment for *H. cinaedi* infection ([Table 1](#tbl0005){ref-type="table"}). Approximately 30--60% of patients have recurrent symptoms [@bib0045]. Carbapenems, aminoglycosides, and tetracyclines showed low minimum inhibitory concentration (MIC) values. Penicillins and cephalosporins showed moderate MIC values. Macrolides, and quinolones showed high MIC values [@bib0045]. The U.S. Centers for Disease Control and Prevention recommends the two to six weeks of antimicrobial treatment, however, recurrence can be seen with these treatment. In addition, patients who were treated with fluoroquinolones may have more recurrent episodes than those who were treated with other antimicrobial agents [@bib0055]. This could be explained by the higher MICs of fluoroquinolones. In our case, recurrent symptoms were observed in spite of the use of meropenem for several weeks; therefore, we re-treated him for intravenous meropenem and oral minocycline for a total of 12 weeks. Further study is needed to determine the appropriate antimicrobial agent, the duration of the antimicrobial treatment, and the pathogenesis of this infection and its recurrence needs to be investigated.

In conclusion, clinicians should be aware of this microorganism when treating patients with bilateral or multi-focal skin and soft tissue infections even if he or she is immunocompetent.
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Previously reported *Helicobacter cinaedi* infections, antimicrobial agents, and duration of the therapy.

Table 1

  Case number   Author        Year   Age (year)   Sex                   Medical history                                                                        Site of infection                        Antimicrobial agents                                                                                                                  Duration of treatment
  ------------- ------------- ------ ------------ --------------------- -------------------------------------------------------------------------------------- ---------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------
  1             Murata S      2015   56           Male                  Bronchial asthma                                                                       Vertebral osteomyelitis and bacteremia   Ceftriaxone                                                                                                                           6 weeks
  2             Haruki Y      2015   64           Male                  None                                                                                   Bacteremia, spondylitis, diskitis        Cefazolin + fosfomycin                                                                                                                8 weeks
  3             Mishima K     2015   48           Male                  Hepatitis C virus infection induced liver cirrhosis, diabetes mellitus, hypertension   Bacteremia, cellulitis                   Cefazolin, relapse, cefazolin, ciprofloxacin, minocycline                                                                             7 days, relapse, 4 months
  4             Ishibashi R   2015   76           Female                Slowly progressive type 1 diabetes, rheumatoid arthritis                               Bacteremia                               Cefepime, cefotiam, minocycline                                                                                                       18 days
  5             Ishibashi R   2015   47           Female                Type 2 diabetes                                                                        Bacteremia, cellulitis                   Cefazolin, cefdinir                                                                                                                   Not reported
  6             Unosawa S     2015   79           Male                  Hypertension                                                                           Infected abdominal aortic aneurysm       Ampicillin/sulbactam, gentamicin + ceftriaxone, sultamicillin                                                                         4 months
  7             Kakuta R      2014   64           Male                  Hypertension, hyperlipidemia                                                           Infected abdominal aortic aneurysm       Ceftriaxone + levofloxacin, doripenem+ vancomycin, ampicillin/sulbactam +minocycline, amoxicillin + minocycline                       More than 6 weeks (not reported)
  8             Kakuta R      2014   59           Male                  None                                                                                   Infected abdominal aortic aneurysm       Piperacillin/tazobactam, faropenem, piperacillin/tazobactam, amoxicillin, minocycline                                                 More than 5 weeks (not reported)
  9             Kakuta R      2014   62           Male                  Myocardial infarction                                                                  Infected abdominal aortic aneurysm       Doripenem, amoxicillin, minocycline                                                                                                   More than 4 weeks (not reported)
  10            Bartels H     2014   71           Male                  Polymyalgia rheumatica, aortic stenosis                                                Endocarditis                             Amoxicillin/clavulanate + gentamicin, ceftriaxone + gentamicin                                                                        6 weeks
  11            Sugiyama A    2014   34           Female                Marfan syndrome, schizophrenia                                                         Meningitis                               Vancomycin + ceftriaxone, meropenem                                                                                                   3 weeks
  12            Kikuchi H     2012   31           Female                Systemic lupus erythematosus, rheumatoid arthritis, necrotizing fasciitis              Bacteremia, cellulitis                   Cefazolin + clindamycin, pazufloxacin, aztreonam, relapse, aztreonam, minocycline                                                     18 days, relapse, 6 weeks
  13            Kim SK        2012   71           Male                  Status post splenectomy, immune hemolytic anemia, aplastic anemia                      Bacteremia                               Piperacillin/tazobactam + levofloxacin                                                                                                20 days
  14            Holst H       2008   61           Male                  None                                                                                   Bacteremia, cellulitis                   Dicloxacillin, penicillin, relapse, rifampicin                                                                                        2 weeks, relapse, 2 weeks
  15--25        Kitamura T    2007   22--79       2 male and 9 female   After the orthopedic surgery                                                           Bacteremia, cellulitis                   Sultamicillin, imipenem, cefotiam                                                                                                     Not reported
  26            Uçkay I       2006   53           Female                Malignant lymphoma                                                                     Bacteremia                               Ceftriaxone + gentamycin, clarithromycin, levofloxacin, relapse, ceftriaxone + doxycycline, amoxicillin, metronidazole, doxycycline   9 weeks, relapse, 3.5 months
  27            Lasry S       2000   20           Male                  None                                                                                   Bacteremia, synovitis                    Ciprofloxacin + rifampicin                                                                                                            12 weeks
  28            Burman WJ     1995   26           Male                  Human immunodeficiency virus infection                                                 Bacteremia                               Oxacillin/dicloxacillin, oxacillin + gentamicin, ciprofloxacin                                                                        31 days
  29            Burman WJ     1995   39           Male                  Acquired immune deficiency syndrome                                                    Bacteremia                               Ciprofloxacin                                                                                                                         21 days
  30            Burman WJ     1995   56           Female                Alcoholism                                                                             Bacteremia                               Cefotetan, clindamycin + gentamicin, amoxicillin/clavulanate                                                                          18 days
  31            Burman WJ     1995   27           Female                Human immunodeficiency virus infection                                                 Bacteremia                               Erythromycin, ciprofloxacin, doxycycline                                                                                              53 days
  32            Burman WJ     1995   36           Male                  Acquired immune deficiency syndrome                                                    Bacteremia                               Cephalexin, ciprofloxacin, doxycycline, ceftriaxone/cefixime                                                                          34 days
  33            Burman WJ     1995   34           Male                  Acquired immune deficiency syndrome                                                    Bacteremia                               Ciprofloxacin                                                                                                                         10 days
  34            Burman WJ     1995   28           Male                  Acquired immune deficiency syndrome                                                    Bacteremia                               Ceftriaxone, ciprofloxacin, doxycycline                                                                                               42 days
